Close Topic Options

Axumin

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.

Prostate cancer is the second leading cause of death from cancer in U.S. Men. In patients with suspected cancer recurrence after primary treatment, accurate staging is an important objective in improving management and outcomes. Ref. Source 7p.

Axumin

I can't imagine being injected with anything that was radioactive but I guess when you're a cancer patient in critical condition you will do whatever is necessary.